Breakthru Medicine

About Breakthru Medicine

Breakthru Medicine focuses on aggressive solid tumors with the highest unmet need by targeting the specific molecular drivers of each tumor and designing precision therapies for patients whose cancers have become resistant to current treatments. The company emphasizes pioneering next-generation oncology treatments, combining scientific excellence with proven drug development expertise to deliver transformative therapies and meaningful value for stakeholders. Its portfolio approach centers on multiple independent programs and platform-enabled discovery, aiming to advance lead programs into clinical trials in the near term.